DK1173194T3 - Rekombinant SP-A til behandlingen eller forebyggelsen af lungeinfektion og -inflammation - Google Patents
Rekombinant SP-A til behandlingen eller forebyggelsen af lungeinfektion og -inflammationInfo
- Publication number
- DK1173194T3 DK1173194T3 DK00912431T DK00912431T DK1173194T3 DK 1173194 T3 DK1173194 T3 DK 1173194T3 DK 00912431 T DK00912431 T DK 00912431T DK 00912431 T DK00912431 T DK 00912431T DK 1173194 T3 DK1173194 T3 DK 1173194T3
- Authority
- DK
- Denmark
- Prior art keywords
- inflammation
- prevention
- treatment
- recombinant
- lung infection
- Prior art date
Links
- 108010007100 Pulmonary Surfactant-Associated Protein A Proteins 0.000 title abstract 2
- 230000004054 inflammatory process Effects 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 208000032376 Lung infection Diseases 0.000 title 1
- 206010035664 Pneumonia Diseases 0.000 title 1
- 102100027773 Pulmonary surfactant-associated protein A2 Human genes 0.000 title 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 102000007615 Pulmonary Surfactant-Associated Protein A Human genes 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002685 pulmonary effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Marine Sciences & Fisheries (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15526899P | 1999-01-19 | 1999-01-19 | |
| PCT/EP2000/000324 WO2000043026A2 (en) | 1999-01-19 | 2000-01-18 | Recombinant sp-a for the treatment or prevention of pulmonary infection and inflammation |
| EP00912431A EP1173194B1 (en) | 1999-01-19 | 2000-01-18 | Recombinant sp-a for the treatment or prevention of pulmonary infection and inflammation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1173194T3 true DK1173194T3 (da) | 2004-10-18 |
Family
ID=22554732
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00912431T DK1173194T3 (da) | 1999-01-19 | 2000-01-18 | Rekombinant SP-A til behandlingen eller forebyggelsen af lungeinfektion og -inflammation |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US7135452B1 (da) |
| EP (1) | EP1173194B1 (da) |
| AT (1) | ATE269101T1 (da) |
| AU (1) | AU774207B2 (da) |
| CA (1) | CA2361276A1 (da) |
| DE (1) | DE60011601T2 (da) |
| DK (1) | DK1173194T3 (da) |
| ES (1) | ES2223478T3 (da) |
| PT (1) | PT1173194E (da) |
| SI (1) | SI1173194T1 (da) |
| WO (1) | WO2000043026A2 (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030158087A1 (en) * | 2000-04-12 | 2003-08-21 | Dietrich Hafner | Novel use of fulmonary surfactant for the prophylaxis or early treatment if acute fulmonary diseases |
| SE0203591D0 (sv) | 2002-12-04 | 2002-12-04 | Siemens Elema Ab | Förfarande för beredning av ett mediakament och en medicinsk anordning |
| RU2238757C1 (ru) * | 2003-06-24 | 2004-10-27 | ООО "Биосурф" | Способ лечения ингаляционных поражений |
| WO2007111496A1 (en) * | 2006-03-28 | 2007-10-04 | Universiteit Utrecht Holding B.V. | Improved carbohydrate recognition domains |
| US20100284969A1 (en) * | 2007-06-05 | 2010-11-11 | Frank Guarnieri | Methods and Compositions for Delivery of Medicaments to the Lungs |
| AU2009324637B2 (en) | 2008-12-10 | 2016-09-08 | Paka Pulmonary Pharmaceuticals, Inc. | Methods and compositions for delivery of medicaments to the lungs |
| EP2637681A4 (en) * | 2010-11-04 | 2015-09-23 | Univ Oklahoma | PEPTIDE COMPOSITIONS FOR DOWN-REGULATING THE TLR-4 SIGNAL PATH AND METHOD FOR THE PRODUCTION AND USE THEREOF |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4659805A (en) * | 1984-12-11 | 1987-04-21 | California Biotechnology, Inc. | Recombinant alveolar surfactant protein |
| US5840527A (en) * | 1984-12-11 | 1998-11-24 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Recombinant alveolar surfactant protein |
| US4912038A (en) * | 1984-12-11 | 1990-03-27 | California Biotechnology Inc. | Recombinant DNA sequence encoding alveolar surfactant protein |
| US4882422A (en) * | 1985-10-24 | 1989-11-21 | Genetics Institute, Inc. | Pulmonary surfactant proteins |
| AU1294888A (en) * | 1987-01-29 | 1988-08-24 | California Biotechnology, Inc. | Recombinant alveolar surfactant protein |
| JP3961029B2 (ja) | 1992-06-24 | 2007-08-15 | 博 木戸 | インフルエンザウィルス感染防止剤 |
| US6267958B1 (en) * | 1995-07-27 | 2001-07-31 | Genentech, Inc. | Protein formulation |
-
2000
- 2000-01-18 EP EP00912431A patent/EP1173194B1/en not_active Expired - Lifetime
- 2000-01-18 US US09/889,348 patent/US7135452B1/en not_active Expired - Fee Related
- 2000-01-18 AU AU34209/00A patent/AU774207B2/en not_active Ceased
- 2000-01-18 AT AT00912431T patent/ATE269101T1/de not_active IP Right Cessation
- 2000-01-18 DK DK00912431T patent/DK1173194T3/da active
- 2000-01-18 CA CA002361276A patent/CA2361276A1/en not_active Abandoned
- 2000-01-18 SI SI200030474T patent/SI1173194T1/xx unknown
- 2000-01-18 PT PT00912431T patent/PT1173194E/pt unknown
- 2000-01-18 WO PCT/EP2000/000324 patent/WO2000043026A2/en not_active Ceased
- 2000-01-18 ES ES00912431T patent/ES2223478T3/es not_active Expired - Lifetime
- 2000-01-18 DE DE60011601T patent/DE60011601T2/de not_active Expired - Fee Related
-
2006
- 2006-04-28 US US11/413,197 patent/US20060194732A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DE60011601D1 (de) | 2004-07-22 |
| AU774207B2 (en) | 2004-06-17 |
| ATE269101T1 (de) | 2004-07-15 |
| PT1173194E (pt) | 2004-10-29 |
| AU3420900A (en) | 2000-08-07 |
| CA2361276A1 (en) | 2000-07-27 |
| EP1173194A2 (en) | 2002-01-23 |
| EP1173194B1 (en) | 2004-06-16 |
| US7135452B1 (en) | 2006-11-14 |
| ES2223478T3 (es) | 2005-03-01 |
| DE60011601T2 (de) | 2005-07-07 |
| US20060194732A1 (en) | 2006-08-31 |
| WO2000043026A3 (en) | 2001-10-18 |
| WO2000043026A2 (en) | 2000-07-27 |
| SI1173194T1 (en) | 2004-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE508735T1 (de) | Pulmonale verabreichung von aminoglykosiden | |
| BR0011433B1 (pt) | Compostos de imidazoquinolinas substituídas com sulfonamida e sulfamida e composição farmaceutica cotendo os mesmos | |
| NO2012018I2 (no) | Canakinumab eller direkte ekvivalenter derav | |
| DK0833649T4 (da) | Proteinhydrolysatpræparater til forebyggelse eller behandling af allergier | |
| DK1181027T3 (da) | Diætetisk eller farmaceutisk præparat til anvendelse til forebyggelsen eller behandling af hyperoxaluri | |
| DE69825526D1 (de) | Korrektur der vorgegebenen Zeit | |
| DK0951473T3 (da) | Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette | |
| NO20030411D0 (no) | Farmasöytiske sammensetninger for behandlingen av smertefulle, inflammatoriske og ulceröse tilstander av fuktige epiteloverflater slik sommukositt, stomatitt og Behcets syndrom | |
| BR0013771A (pt) | Composto, métodos de tratamento de uma infecção viral em um mamìfero, de inibir a transcriptase reversa do hiv, e de prevenção da infecção do hiv ou de tratar a infecção do hiv, uso de um composto, e, composição farmacêutica | |
| ATE275631T1 (de) | Rekombinanter venezolanische-equine- pferdeenzephalitis-virusimpstoff | |
| DK1173194T3 (da) | Rekombinant SP-A til behandlingen eller forebyggelsen af lungeinfektion og -inflammation | |
| HRP20050024A2 (en) | Pegylated t20 polypeptide | |
| EP1180999A4 (en) | RECOMBINANT VACCINE AGAINST BOTULINUM NEUROTOXIN | |
| DE60006412D1 (de) | Oxazinochinolone zur behandlung von viralen infektionen | |
| AU2002322082A1 (en) | Pharmaceutical composition for the treatment of viral infection | |
| DE60017924D1 (de) | Rekombinante, adenovirale vektoren und ihre verwendung zur behandlung von leberzirrhose | |
| DK1276495T3 (da) | Anvendelse af rekombinante lungesurfactant-præparater til tidlig behandling af akutte lungesygdomme | |
| EE200000694A (et) | Inimese rekombinantse iterferooni beeta-1a (IFN-ß-1a) formulatsioon | |
| DK0666755T3 (da) | Inhibering af HIV-infektion | |
| ATE255594T1 (de) | Hepatitis b inhibitoren | |
| DK1052991T3 (da) | Topisk anvendelse af loperamid til behandling af mikrobielle infektioner | |
| DE60112117D1 (de) | Warmgeformte feste arzneizusammensetzung zur gesteuerten wirkstoffabgabe von perindopril | |
| ITMI940192A0 (it) | Forma purificata di streptogramine sue preparazione e le composizioni che la contengono | |
| IL158411A0 (en) | Peptides that inhibit viral infections and compositions containing the same | |
| DK1140090T3 (da) | Anvendelse af phanquinon til behandlingen eller hindringen af hukommelsessvigt |